Refolding of recombinant porcine growth hormone in a reducing environment limits in vitro aggregate formation
- 4 November 1991
- journal article
- Published by Wiley in FEBS Letters
- Vol. 292 (1-2) , 187-190
- https://doi.org/10.1016/0014-5793(91)80864-y
Abstract
Recombinant porcine growth hormone (rPGH) solubilized from bacterial inclusion bodies (IBs) using a cationic surfactant was oxidized to form disulphide bonds in a simple butter solution containing 2-mercaptoethanol within an empirically derived optimal molar ratio of 2-mercaptoethanol:protein. A final yield of 55% monomeric rPGH was achieved at protein concentrations of up to 5 mg/ml without the need for removal of the 2-mercaptoethanol or the use of chaotrophic agents. In the absence of 2-mercaptoethanol only 15% monomeric rPGH was obtained, with the majority forming higher molecular weight aggregates. Using the procedure derived for porcine growth hormone, it may be possible to obtain high yields of native protein and overcome the need for using low protein concentrations and chaotrophic agents during in vitro refolding of other disulphide bonded recombinant proteinsKeywords
This publication has 7 references indexed in Scilit:
- Determination of minor components in mixtures using EXAFSAnalytica Chimica Acta, 1990
- Refolding and aggregation of bovine carbonic anhydrase B: quasi-elastic light scattering analysisBiochemistry, 1990
- Cosolvent Assisted Protein RefoldingNature Biotechnology, 1990
- Solubility as a Function of Protein Structure and Solvent ComponentsNature Biotechnology, 1990
- Production of Soluble Recombinant Proteins in BacteriaNature Biotechnology, 1989
- The purification of eukaryotic polypeptides synthesized in Escherichia coliBiochemical Journal, 1986
- On the Recovery of Genetically Engineered Proteins fromEscherichia coliSeparation Science and Technology, 1986